Recombinant yellow fever virus and methods of use thereof

   
   

The present invention provides recombinant yellow fever viruses (YFV), particularly live attenuated recombinant YFV, which comprise exogenous (i.e., non-YFV) nucleotide sequences which encode exogenous (i.e., non-YFV) amino acid sequences. These recombinant YFV viruses comprise an exogenous nucleic acid. Infection of a host cell with a recombinant YFV provides for expression of the exogenous nucleic acid in a host cell and production of an antigenic polypeptide encoded by the exogenous nucleic acid. Such recombinant YFV are useful in eliciting an immune response to the exogenous polypeptide.

 
Web www.patentalert.com

< Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics

< Ganoderma lucidum spores for treatment of autoimmune diseases

> Compositions and methods for drug delivery using pH sensitive molecules

> 2, 4-disubstituted-pyridine N-oxides useful as HIV reverse transcriptase inhibitors

~ 00183